VC-Backed Startups May Have Advantage Over Other Firms If User Fees Pass
This article was originally published in The Gray Sheet
Venture capital-backed medical device developers would sustain a muted impact from having to pay user fees for 510(k)s and PMAs compared with their non-venture-backed counterparts, speakers agreed at the Medical Device Manufacturers Association annual meeting May 23 in Washington, D.C
You may also be interested in...
Industry supporters of medical device user fees are assuming a formidable challenge by linking the legislative proposal with the "Medical Device Amendments of 2001" (HR 3580), introduced by Reps. Jim Greenwood (R-Penn.) and Anna Eshoo (D-Calif.)
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.